Hooke Bio are developing a fully integrated high-throughput (HT) microphysiological system (MPS) for 3D mini organ screening. The patent-protected "Mera" system can generate biological data from 3D mini organs with the aim of replacing animal models in preclinical studies while also accelerating drug development. By adopting MPS technologies, additional value of the order of $3 bn can be added to the drug toxicity screening sector alone.